Abstract
Background
Management of patients with hyperglycaemia undergoing vascular and cardiac surgery is important, with mounting evidence that hyperglycaemia in this setting is associated with worse outcomes. Evidence-based guidelines for the management of these patients have been limited.
Methods/Results
Our institution was aware of the lack of standardization of care in this growing population group and formed a multidisciplinary guideline development group to develop evidence-based guidelines to standardize the perioperative management of hyperglycaemia.
Conclusion
This series of articles outlines the process of developing evidence-based guidelines and the recommendations for perioperative management of patients with hyperglycaemia and diabetes undergoing cardiac and vascular surgery at our institution.
Similar content being viewed by others
Abbreviations
- ADA:
-
American Diabetes Association
- BSL:
-
Blood sugar level
- CABG:
-
Coronary artery bypass grafting
- CVVHDF:
-
Continuous veno-venous haemodialysis and filtration
- CII:
-
Continuous insulin infusion
- DNE:
-
Diabetes Nurse Educator
- FBG:
-
Fasting blood glucose
- eGFR:
-
Estimated glomerular filtration rate
- GDG:
-
Guideline Development Group
- GIK:
-
Potassium, Insulin and glucose infusion
- HbA1c:
-
Glycosylated haemoglobin
- ICU:
-
Intensive care unit
- IFG:
-
Impaired fasting glucose
- IGT:
-
Impaired glucose tolerance
- NHMRC:
-
National Health and Medical Research Council
- OGTT:
-
Oral glucose tolerance test
- RBG:
-
Random blood glucose
- TPN:
-
Total parenteral nutrition
- WHO:
-
World Health Organisation
References
World Health Organization (WHO) (2006) Global strategy on Diet, Physical Activity and Health. Diabetes. http://www.who.int/dietphysicalactivity/publications/facts/diabetes/en/. Accessed September 19, 2006
Dunstan DW, Zimmet PZ, Welborn T, on behalf of the AusDiab Steering Committee et al (2001) Diabesity and associated disorders in Australia-2000. The accelerating epidemic. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab). International Diabetes Institute, Melbourne
Latham R, Lancaster A, Covington J et al (2001) The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 22(10):607–612
Lauruchskat AH (2005) Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing CABG. Circulation 112(16):2397–2402
Swenne CL, Lindholm C, Borowiec J et al (2005) Peri-operative glucose control and development of surgical wound infections in patients undergoing coronary artery bypass graft. J Hosp Infect 61:201–212
Dunstan DW, Zimmet PZ, Welborn TA et al (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25:829–834
Consortium DAGD (2005) National evidence based guidelines for the management of type 2 diabetes, 2nd edn. National Health and Medical Research Council, Canberra
(1998) Standards of medical care for patients with diabetes mellitus. Diabetes Care 21(Suppl 1):23S–31S
Ten facts about Diabetes. http://www.mydr.com.au/default_new.asp?article=2885. Accessed September 19, 2006
Uusitupa MI, Niskanen LK, Sitonen O et al (1993) Ten year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36(11):1175–1184
Hypertension in Diabetes Study Group (1995) Prevalence of hypertension in newly presenting Type 2 diabetic patients and the association of risk factors for cardiovascular and diabetic complications. J Hypertension 11:309–317
Kadoi Y, Saito S, Fujita N et al (2005) Risk factors for cognitive dysfunction after coronary artery bypass graft surgery in patients with type 2 diabetes. J Thorac Cardiovasc Surg 129(3):576–583
NBPA Committee (2004) Hypertension Management Guide for Doctors, 2004 Guideline. Heart Foundation, Sydney
Guvener M, Pasaoglu I, Demircin M et al (2002) Perioperative hyperglycaemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 49(5):531–537
Trick WE, Scheckler WE, Tokars JI et al (2000) Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg 119(1):108–114
Cohen O, Dankner R, Chetrit A et al (2003) Multidisciplinary intervention for control of diabetes in patients undergoing coronary artery bypass graft (CABG). Cardiovasc Surg 11(3):195–200
Salpeter SR, Greyber E, Pasternak GA et al. (2006) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Library, CD002967
DAGD Consortium (2009) National evidence based guidelines for blood glucose control in type 2 diabetes. National Health and Medical Research Council, Canberra
Gandhi GY, Nuttall GA, Abel MD et al (2007) Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Ann Intern Med 146:233–243
Ouattara A, Lecomte P, Le Manach Y et al (2005) Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 103(4):687–694
Gandhi GY, Nuttall GA, Abel MD et al (2005) Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 80(7):862–866
Whipple AO, Frank VO (1937) Adenoma of islet cell tumours with hyperinsulinism. Am J Pathol 14:125–138
Vriesendorp TM, DeVries JH, Holleman F et al (2005) The use of two continuous glucose sensors during and after surgery. Diabetes Technol Ther 7(2):315–322
Lazar HL, Chipkin SR, Fitzgerald CA et al (2004) Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events [see comment]. Circulation 109(12):1497–1502
Gavin LA (1989) Management of diabetes mellitus during surgery. West J Med 151:1525–1529
Rady MY, Johnson DJ, Patel BM et al (2005) Influence of individual characteristics on outcome of glycaemic control in intensive care unit patients with and without diabetes mellitus. Mayo Clin Proc 80(12):1558–1567
Whitcomb BW, Pradhan EK, Pittas AG et al (2005) Impact of admission hyperglycaemia on hospital mortality in various intensive care unit populations. Crit Care Med 33(12):2772–2777
Freire AX, Bridges L, Umpierrez GE et al (2005) Admission hyperglycaemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest 128(5):3109–3116
Christiansen C, Toft P, Jorgensen HS et al (2004) Hyperglycaemia and mortality in critically ill patients: a prospective study. Intensive Care Med 30:1685–1688
Zerr KJ, Furnary AP, Grunkemeier GL et al (1997) Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63:356–361
Carr JM, Sellke FW, Fey M et al (2005) Implementing tight glucose control after coronary bypass surgery. Ann Thorac Surg 80:902–909
Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345(19):1359–1367
Furnary A, Wu Y, Bookin SO (2004) Effect of hyperglycaemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 10(2):21–33
NICE-SUGAR Study Investigators (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360(13):1283–1297
Gore MO, McGuire DK (2009) The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context. Diab Vasc Dis Res 6(1):53–55
UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).[see comment]. Lancet 352(9131):837-853 [erratum: Lancet 1999 Aug 14;354(9178):602]
Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356(24):2457–2471
Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26(11):3160–3167
Disclosure
Dr. Wong has received honoraria from Sanofi Aventis, Novo Nordisk, and Lilly Pharmaceuticals for providing educational sessions.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was conducted on behalf of the Southern Health Peri-operative Diabetes Management Guideline Group.
Rights and permissions
About this article
Cite this article
Wong, J., Zoungas, S., Wright, C. et al. Evidence-based Guidelines for Perioperative Management of Diabetes in Cardiac and Vascular Surgery. World J Surg 34, 500–513 (2010). https://doi.org/10.1007/s00268-009-0380-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-009-0380-0